The Role of Pro-angiogenic Immune Cells in Human Pregnancies | NCT01177020

Studies
The Role of Pro-angiogenic Immune Cells in Human Pregnancies

NCT01177020

Sponsor

Hillel Yaffe Medical Center

Status

Unknown status

Last Update Posted

Aug 6, 2010Estimated

Enrollment

300Estimated

Phase

Not provided

Conditions

Fetal Growth Retardation
Preeclampsia

Interventions

Biological specimen

Countries

Israel

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Aug 2010

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 2010

Primary Completion Date

Aug 2011Estimated

Completion Date

Dec 2011Estimated

First Submitted Date

May 12, 2010

First Submission Date that Met QC Criteria

Aug 5, 2010

First Posted Date

Aug 6, 2010Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Aug 5, 2010

Last Update Posted Date

Aug 6, 2010Estimated

Description Module

Brief Summary

Identification of the presence of proangiogenic immune cells in normal human placentas may enable predication of some pregnancy disorders.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

300Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Placentas after delivery or abortion			Other: Biological specimen

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Biological specimen	Other	Biological specimen taken from placenta	Placentas after delivery or abortion

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
To find the angiogenic potential of proangiogenic immune cells derived from human placentas.		Two years

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Placentas that have been delivered in the Medical Center

Exclusion Criteria:

None

Accepts Healthy Volunteers

Yes

Sex

Female

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

Placentas after delivery or abortion

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Elad Mei-Dan, MD	Contact	972-4-6304248		eladmei@yahoo.com

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Hillel Yaffe Medical Center	Recruiting	Hadera		38100	Israel

Condition Browse Module

MeSH Terms

ID	Term
D005317	Fetal Growth Retardation
D011225	Pre-Eclampsia

Ancestor Terms

ID	Term
D005315	Fetal Diseases
D011248	Pregnancy Complications
D005261	Female Urogenital Diseases and Pregnancy Complications
D000091642	Urogenital Diseases

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D018070	Biological Specimen Banks

Ancestor Terms

ID	Term
D006268	Health Facilities
D005159	Health Care Facilities Workforce and Services

Browse Leaves

Not provided

Browse Branches

Not provided